Skip to main content

Immunotherapy

Online First
Characterization of A Dose-Dense Doxorubicin and Cyclophosphamide Regimen for Triple-Negative Breast Cancer Within the KEYNOTE-522 Trial
Samantha Hodges, PharmD; Katelyn Patterson, PharmD; Vera Ljucovic, PharmD
Read More
Online First
Characterizing Lenalidomide Dose Modifications Among Black and Non-Black Patients Receiving Induction Therapy for Newly Diagnosed Multiple Myeloma
Laura Fan Sun, PharmD, BCOP; Natalie Brumwell, PharmD; Kevin Hall, PharmD; Kristina Murphy, PharmD; Jeffrey Switchenko, PhD; Yichun Cao, MPH, et al.
Read More
Online First
Outcomes of Early Versus Delayed Initiation of Immunotherapy in Patients With Extensive-Stage Small Cell Lung Cancer
Matthew Warrick, PharmD, BCPS, BCOP; Rebecca Worden, PharmD, BCOP; Carly Kesler, PharmD, BCOP; Katie Murto, PharmD, BCOP; Amanda Edwards, PharmD, BCOP, CPP
Read More
Evaluation of Serious Immune-Related Adverse Event Incidence in 200-mg Versus 400-mg Pembrolizumab Regimens
Arlet Bacallao Molina, PharmD; Natoya Muirhead, PharmD, BCOP; Erika Rugay, PharmD, BCOP; Karin Thatcher, PharmD, BCPS; Jovino Hernandez, PharmD, BCPS
Read More
Online First
Assessment of Appropriate Anticoagulation in Patients With Multiple Myeloma—A Health-System Specialty Pharmacy Retrospective Evaluation
Addie Planas, PharmD, CSP, CPh; Brittany Alvarez, PharmD, MBA; Beatriz Jimenez Cadilla, PharmD, BCACP; Karina Delgado, PharmD, MBA, BCPS; Jacqualine Igwe, PharmD, BCPS, et al.
Read More
Advancing Merkel-Cell Carcinoma Treatment With Immunotherapy
Read More
Online First
Management of Severe Hypersensitivity Reaction and Serum Sickness in a Case of Aplastic Anemia: Case Report Using Tocilizumab
David C. Sabatino, PharmD, BCOP; Alina Varabyeva, PharmD, BCOP; Joseph Jurcic, MD
Read More
Tisotumab Vedotin With Pembrolizumab in the Treatment of a Patient With Metastatic Vaginal Cancer: A Case Report
Maja Hill, PharmD; Laura Nice, PharmD, BCOP; Casey Moffa, DO; Thomas Krivak, MD
Read More
HARMONI-2 Demonstrating “Significant” Improvement in PFS With Ivonescimab Over Pembrolizumab
Read More
Treatment With Anakinra After Initially Receiving Tocilizumab for Cytokine Release Syndrome
Ailin Kim, PharmD, BCOP; Monank Patel, PharmD, BCOP; Walter Domingo, PharmD, BCOP; Theresa Latchford, RN, MS; Matthew Frank, MD, PhD
Read More
Page 1 of 4
Results 1 - 10 of 38